Kathmandu: Nepal has banned imports from 16 Indian pharmaceutical companies including Divya Pharmacy, which manufactures Patanjali products, saying these companies did not follow the mandatory “good manufacturing practices” of the World Health Organization (WHO).
Earlier, WHO issued a global alert Cough syrups made in India It is said to be linked to the death of children in the West African country.
The Department of Drug Administration (DDA) of Nepal has published a list of 16 such companies, including Radiant Parenterals Ltd., Mercury Laboratories Ltd., Alliance Biotech, Captab Biotec, Aglowmed Limited, Zee Laboratories Ltd, Daffodils Pharmaceuticals Ltd, GLS pharma Limited. , Unijules Life Science Ltd, Concept Pharmaceuticals Pvt., Shree Anand Life Sciences Ltd, IPCA laboratories Ltd, Cadila Healthcare Ltd, Dial Pharmaceuticals, Aglowmed Limited and Mackur laboratories Ltd.
“After inspecting the manufacturing facilities of the pharmaceutical companies that applied to export their products to our country, we have published a list of companies that do not comply with the good manufacturing practices of the World Health Organization.”
Santosh KC, DDA spokesperson said.
Nepal’s drug regulatory authority has also published a list of 46 drug manufacturing companies that comply with WHO standards. The DDA sent its drug inspectors to India in April and July this year to inspect pharmaceutical companies that applied for permission to import their products into Nepal.
Also Read: Center Urges States To Sequencing Genome Samples Of Positive Cases Amid Covid Spike In China